“…Presuming that the GAG deletion acts in a dominant-negative manner, the underlying molecular mechanism might be disruption of an oligomeric protein complex. 13 The phenotypic spectrum of this mutation has been delineated in North American, 3 British, 4 French, 5 German, 6,7 and Russian 14 patients with dystonia, thus extending the originally described phenotype of the Ashkenazi Jewish founder population. 9 This includes spread of symptoms with involvement of craniocervical, especially cranial, muscles (after limb onset), which is not unusual in European patients.…”